Home  /  Resource Library  /  Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions – Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia

Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions – Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia

Results of a study investigating temporarily stoppages in ibrutinib to reduce incidence of infections in patients with CLL.